EGFR and neoplasm: Therefore, an antibody (mAb 806) specifically targeting this sterically hidden epitope would be ideal for detecting cancer EVs secreted by EGFR-amplified tumour cells9, as the same active version of EGFR (aEGFR) is also shared on the tumour-secreted EVs6.